Edit Symbol List
Don't know the stock symbol? Use the symbol lookup tool.
Alphabetize the sort order of my symbols
ETFs with PDLI as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|1.45%||First Trust DJ Global Select Dividend (FGD)||+1.58 (5.75%)|
|0.96%||WisdomTree SmallCap Earnings Fund (EES)||+0.14 (0.17%)|
|0.91%||WisdomTree Trust SmallCap Dividend Fund (DES)||+1.15 (1.71%)|
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
PDL BioPharma manages a portfolio of patents and royalty assets, consisting primarily of its Queen et al. antibody humanization patents and license agreements with various biotechnology and pharmaceutical companies. PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases for which it receives significant royalty revenue. PDL is currently focused on intellectual property asset management, acquiring new income generating assets and maximizing value for its shareholders. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL was founded in 1986 and is headquartered in Incline Village, Nevada. In 2011, PDL initiated a strategy to bring in new income generating assets from the healthcare sector. ... More ...